WHAT´S NEW in Spondyloarthritis?
In this section you will be able to identify the new content uploaded regularly .
Duration 6:03
The Importance of addressing muscloskeletal signs & symptoms in psoriatic arthritis
Prof. William Tillett
Consultant rheumatologist, royal national hospital for rheumatic diseases senior lecturer, pharmacy and pharmacology, University of Bath, UK
Duration 5:15
The Role of JAKs in SpA
Prof. Eduardo Mysler
Director of the medical research organization, principal investigator and clinical protocol designer for medical institutions, OMI in Buenos Aires, Argentina
Duration 7:15
Unmet Needs in Axial SpA & PsA
Prof. Andrew Ostor
Consultant rheumatologist, Cabrini medical cente, and a Melbourne investigator, Emeritus research unit, Melbourne, Australia
Duration 8:05
Upadacitinib for Active Psoriatic Arthritis Refractory to Biologics (SELECT-PSA 2)
Prof. Philip Mease
Swedish medical center/ Providence St Joseph Health and university of Washington, Seattle, Washington
Duration 7:21
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis (SELECT-PSA 1)
Prof. Ian Mclnnes
University of Glasgow
Duration 8:00
Efficacy and Safety of Upadacitinib in a randomized, double-blind, placebo-controled,multicenter phase 2/3 clinical study of patients with active ankylosing spondylitis (SELECT-AXIS 1)
Prof. Desiree Van Der Heijde
Leiden University Medical Center, Leiden, The Netherlands
Duration 1:20
Psoriatic Arthritis Disease State
Duration 1:11
Ankylosing Spondylarthritis Disease State
Duration 1:44
Exploring the JAK-STAT Pathway
Duration 3:44
RA EVEREST: Striving for the highest level of care